Cardiologists discuss the risks of soluble stent
In order to properly determine what the risks are of a soluble stent in the heart, the Dutch Association for Cardiology Monday a consultation conducted with international colleagues.
“In it we look and see whether all patients with such a stent called to be and what the best advice is,” says vice president Hans Bosker of the NVVC.
Friday it became known that patients from the Albert Schweitzer Hospital in Dordrecht which is a biologically soluble stent in the heart, until three years after the placement of this stent, an additional blood thinner need to take.
According to Bosker, cardiologist in the Rijnstate hospital in Arnhem, it is still not clear “whether it is a serious problem”. “There now seems to be a question of a small increased risk of clot formation.”